Advanced search×

Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.

Raza Malik, Michelle Lai, Amama Sadiq, Rory Farnan, Shruti Mehta, Imad Nasser, Tracy Challies, Detlef Schuppan, and Nezam Afdhal

J Gastroenterol Hepatol 25(9):1562-8 (2010) PMID 20796156

Non-invasive diagnosis of compensated cirrhosis is important. We therefore compared liver stiffness by transient elastography, APRI score, AST/ALT ratio, hyaluronic acid and clinical signs to determine which modality performed best at identifying compensated cirrhosis.

DOI: 10.1111/j.1440-1746.2010.06371.x
Version: za2963e q8za0 q8zb6 q8zc9 q8zd6 q8ze3 q8zf7 q8zg7
Buy PDF

Similar articles you may find interesting…

  1. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication.
    F A K FA Mazari, S S Gulati, ... I C IC Chetter

    Ann Vasc Surg 24(1):69-79 (2010) PMID 19762206

    All groups were well matched at baseline. Twenty-one patients withdrew. Results are as follows: Intragroup analysis: All groups demonstrated significant clinical and QoL improvements (Friedman test, p<0.05). SEP (60 patients, 8 withdrew)-62.7% of patients (n=32) improved following treatment [20 mild...
    Buy PDF
  2. The effects of droperidol and ondansetron on dispersion of myocardial repolarization in children.
    Disha D Mehta, Shubhayan S Sanatani, and Simon D SD Whyte

    Paediatr Anaesth 20(10):905-12 (2010) PMID 20849495

      Droperidol and ondansetron, in therapeutic anti-emetic doses, produce equivalent, clinically insignificant QT prolongation and negligible Tp-e prolongation, suggesting that neither is torsadogenic in healthy children at these doses. © 2010 Blackwell Publishing Ltd....
    Buy PDF
  3. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    M J MJ Robbins, A J AJ Baskerville, ... R N RN Grüneberg

    Diagn Microbiol Infect Dis 12(3 Suppl):65S-76S (1989) PMID 2791500

    We have determined the in vitro activity of lomefloxacin against a wide range of clinical bacterial isolates and compared it with that of other fluoro-quinolones and some unrelated antimicrobials. Lomefloxacin was very active against Enterobacteriaceae (MIC90, 0.5 micrograms/ml) with activity compar...
    Buy PDF